Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.405, 2003-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
A Benefit-Risk Assessment of Basiliximab in Renal Transplantation
By Boggi Ugo
Drug Safety, Vol. 27, Iss. 2, 2004-01 ,pp. :
Access to resources
Recommend
Cost Evaluation of Basiliximab Treatment for Renal Transplant Patients in Japan
By Hasegawa T.
PharmacoEconomics, Vol. 21, Iss. 11, 2003-01 ,pp. :
Basiliximab: A Review of its Use as Induction Therapy in Renal Transplantation
Drugs, Vol. 63, Iss. 24, 2003-01 ,pp. :
By Walters S.J. Whitfield M. Akehurst R.L. Chilcott J.B.
PharmacoEconomics, Vol. 21, Iss. 2, 2003-01 ,pp. :